AIM ImmunoTech AIM
NYSE AIM
$0.17 +0.00 (+2.70%)
As of: Oct 21, 2026 · 3:55 PM EDT

AIM ImmunoTech (AIM) Long-Term Debt Issuances (2017 - 2025)

Updated

AIM ImmunoTech (AIM) posted Long-Term Debt Issuances of $2.5 million for Q4 2025.

Analysis

AIM ImmunoTech (AIM) Long-Term Debt Issuances (2017 - 2025) Analysis & Trends

For FY2025, AIM ImmunoTech's Long-Term Debt Issuances came in at $2.75 million, up 10.0% from FY2024.

  • In prior years, AIM ImmunoTech's Long-Term Debt Issuances was $2.5 million in FY2024.
  • The Q4 2025 figure stands as the lowest quarterly Long-Term Debt Issuances since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 AIM ImmunoTech 2.92 Mn -18.38 Mn 21,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.50 Mn
Sep 30, 2024 133,000.00
Jun 30, 2024 -133,000.00
Mar 31, 2024 2.50 Mn
Dec 31, 2019 1.73 Mn
Dec 31, 2018 39,000.00
Sep 30, 2018 3.02 Mn
Mar 31, 2018 4.08 Mn
Dec 31, 2017 357,000.00
Sep 30, 2017 937,000.00
API Access

AIM ImmunoTech Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=AIM&period=max&api_key=YOUR_API_KEY